Are you Dr. Riddell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
Seattle, WA 98195Phone+1 206-667-5249
Summary
- Dr. Stanley Riddell, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center and Fred Hutch Cancer Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1989
University of ManitobaClass of 1979
Certifications & Licensure
WA State Medical License 1986 - 2026- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults Start of enrollment: 1998 Sep 01
Publications & Presentations
PubMed
- Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients.Jordan Gauthier, Emily C Liang, Jennifer J Huang, Erik Lesley Kimble, Alexandre V Hirayama
Blood Advances. 2025-01-16 - 1 citationsSingle-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy.David G Coffey, Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J Cowan
Blood. 2025-01-09 - Phase 1 Study of ROR1 Specific CAR T Cells in Advanced Hematopoietic and Epithelial Malignancies.Carla A Jaeger-Ruckstuhl, Jennifer M Specht, Jenna M Voutsinas, Hugh R MacMillan, Qian Vicky Wu
Clinical Cancer Research. 2024-10-28
Press Mentions
Tip Sheet: Celebrate Holidays Safely, COVID-19 Vaccines, Challenges in HIV Vaccine Trials — and New Insights on EvolutionDecember 2nd, 2020- The Latest on Health Technology and Cancer TreatmentsAugust 20th, 2020
- Cancer Tor the Biography of Josef Issels Md Who Brought Hope to the World with His RevolutioJune 28th, 2020
- Join now to see all
Grant Support
- Strategies To Improve The Adoptive Transfer Of T CellsNational Cancer Institute2010–2012
- CD8+ T Cell Immunity To CytomegalovirusNational Institute Of Allergy And Infectious Diseases2009–2012
- Targeted Immunotherapy Of Breast Cancer With Central Memory T CellsNational Cancer Institute2010–2011
- Targeted Therapy Of All With Gene-Modified Central Memory T CellsNational Cancer Institute2009–2011
- Targeting Alloreactivity For Leukemia EradicationNational Cancer Institute2007–2011
- Strategies To Enhance Adoptive Transfer Of T Cell ClonesNational Center For Research Resources2006–2011
- Evaluating The Engineering Of Cytomegalovirus-Specific CD8+ T Cell ClonesNational Center For Research Resources2010
- Analysis Of A Novel Subset Of Human CD8+ Memory Cells With Stem Cell QualitiesNational Institute Of Allergy And Infectious Diseases2009–2010
- Strategies To Enhance Adoptive Transfer T Cell ClonesNational Cancer Institute2005–2009
- Consent To Participate As A Donor Of Peripheral Blood Mononuclear CellsNational Center For Research Resources2004–2007
- CD8+T Cell Immunity To CytomegalovirusNational Institute Of Allergy And Infectious Diseases2003–2007
- Phase I Study Of Adoptive Immunotherapy After Stem Cell TransplantNational Center For Research Resources2004–2006
- Conditional Regulation Of T Cell Survival In ImmunotherapyNational Heart, Lung, And Blood Institute2005
- Safety And Efficacy Of Cellular Adoptive ImmunotherapyNational Center For Research Resources2005
- Safety And Efficacy Of Cellular Adoptive ImmunotherapyNational Center For Research Resources2004
- Evaluation Of A Novel Suicide GeneNational Center For Research Resources2003
- Minor Histocompatibility Antigen--Graft Versus LeukemiaNational Cancer Institute2002
- Novel Suicide Gene For Therapy Of Graft VS Host DiseaseNational Heart, Lung, And Blood Institute2000–2002
- Treatment Of HIV With Gene Modified CD8+ T Cell ClonesNational Institute Of Allergy And Infectious Diseases1998–2001
- Reconstitution Of CMV Immunity In Hiv-Infected HostsNational Institute Of Allergy And Infectious Diseases1997–2001
- Treatment Of Malignancy With Gene Modified T Cells And T Cell ClonesNational Cancer Institute1997–2001
- HIV Treatment With Gene Modified CD8+ T Cell ClonesNational Institute Of Allergy And Infectious Diseases1997
